PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
07-May-2025 Major mass photometry milestone achieved by Refeyn with 500th installation globally Refeyn
07-May-2025 NuCana Prices $7 Million Registered Direct Offering NuCana
07-May-2025 ELRIG Announces Keynote Speakers for Drug Discovery 2025 ELRIG
07-May-2025 Vetter Prioritizes Continuity and Action in its Sustainability Efforts Vetter
07-May-2025 Immunotoxins Market to Hit USD 345.5 Million in 2034 Global Market Insights, Inc.
07-May-2025 Priothera Appoints Dr. Jens Hasskarl as Chief Medical Officer to Drive Late-Stage Clinical Development of Mocravimod, a S1P Receptor Modulator for Acute Myeloid Leukemia (AML) Priothera
07-May-2025 Beacon Therapeutics announced positive data from Phase II DAWN trial Syncona Limited
07-May-2025 The European Association of Endoscopic Spine Surgery is born to lead medical excellence and surgical innovation in Europe European Association of Endoscopic Spine Surgery
07-May-2025 Black Book Research Celebrates Women's Health Month With Complimentary Release of Comprehensive 2025 Industry Report on Women's Health IT Innovations ACCESS Newswire
07-May-2025 Theriva Biologics Announces Pricing of $7.5 Million Public Offering Theriva Biologics
07-May-2025 AcutePet Urgent Care Opens in Summerville, SC - Bringing Affordable Emergency-Level Care to Local Pet Owners ACCESS Newswire
07-May-2025 Theriva™ Biologics Announces Primary Endpoints for Efficacy and Safety Achieved in VIRAGE Phase 2b Clinical Trial of VCN-01 with Gemcitabine/nab-Paclitaxel in Newly-Diagnosed Metastatic Pancreatic Cancer Patients Theriva™ Biologics
07-May-2025 Tiziana Life Sciences Announces Comprehensive Positive Results from Study of Nasal Foralumab in Patients with Multiple Sclerosis Tiziana Life Sciences
07-May-2025 UK-India trade agreement does not support UK life sciences ambitions, says ABPI ABPI
07-May-2025 Personalized Treatment Plans Influence European Public’s Willingness to Share Health Data Johnson & Johnson MedTech
07-May-2025 Medacta announces the results of today's Annual General Meeting Medacta Group SA
07-May-2025 Enhertu followed by THP before surgery showed statistically significant and clinically meaningful improvement in pathologic complete response in patients with high-risk HER2-positive early-stage breast cancer in DESTINY-Breast11 Phase III trial Astrazeneca
07-May-2025 Fresenius Q1/25: Strong start to 2025 – #FutureFresenius Rejuvenate phase kicked-off with excellent momentum Fresenius
07-May-2025 Emmes Groups' OptymEdge to launch the first dedicated ophthalmology clinical trial platform at ARVO 2025 OptymEdge, an Emmes Group company.
07-May-2025 Viatris Announces Quarterly Dividend Viatris